The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World
To control the COVID-19 pandemic, many countries implemented vaccination and imposed societal restrictions both at the national level and for international travel. As a check of corona status, COVID passes have been issued. A COVID pass could be obtained when either fully vaccinated against COVID-19...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1407 |
_version_ | 1797576477853614080 |
---|---|
author | Jasmijn Stroo Michaëla Lepolder Jean-Luc Murk Ger T. Rijkers |
author_facet | Jasmijn Stroo Michaëla Lepolder Jean-Luc Murk Ger T. Rijkers |
author_sort | Jasmijn Stroo |
collection | DOAJ |
description | To control the COVID-19 pandemic, many countries implemented vaccination and imposed societal restrictions both at the national level and for international travel. As a check of corona status, COVID passes have been issued. A COVID pass could be obtained when either fully vaccinated against COVID-19, or after recovering from a documented COVID-19 episode, or after a recent (24–48 h) negative SARS-CoV-2 antigen test. A global analysis of SARS-CoV-2 immune status determined by past infection and/or vaccination, vaccination rates, as well as societal restrictions in controlling the COVID-19 pandemic is presented. The data show that across the world, vaccination was more effective in reducing SARS-CoV-2 infections with the delta variant than the omicron variant. Strict societal restrictions could control spread of the virus, but relief of the restrictions was associated with an increase in omicron infections. No significant difference in SARS-CoV-2 infections were found when comparing countries or territories which did or did not implement a COVID pass. |
first_indexed | 2024-03-10T21:52:30Z |
format | Article |
id | doaj.art-5fabe2d2cfb04eb485c6cf900a2ad6ad |
institution | Directory Open Access Journal |
issn | 2076-393X |
language | English |
last_indexed | 2024-03-10T21:52:30Z |
publishDate | 2023-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj.art-5fabe2d2cfb04eb485c6cf900a2ad6ad2023-11-19T13:18:31ZengMDPI AGVaccines2076-393X2023-08-01119140710.3390/vaccines11091407The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the WorldJasmijn Stroo0Michaëla Lepolder1Jean-Luc Murk2Ger T. Rijkers3Science Department, University College Roosevelt, 4331 CB Middelburg, The NetherlandsScience Department, University College Roosevelt, 4331 CB Middelburg, The NetherlandsMicrovida Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, 5022 GC Tilburg, The NetherlandsScience Department, University College Roosevelt, 4331 CB Middelburg, The NetherlandsTo control the COVID-19 pandemic, many countries implemented vaccination and imposed societal restrictions both at the national level and for international travel. As a check of corona status, COVID passes have been issued. A COVID pass could be obtained when either fully vaccinated against COVID-19, or after recovering from a documented COVID-19 episode, or after a recent (24–48 h) negative SARS-CoV-2 antigen test. A global analysis of SARS-CoV-2 immune status determined by past infection and/or vaccination, vaccination rates, as well as societal restrictions in controlling the COVID-19 pandemic is presented. The data show that across the world, vaccination was more effective in reducing SARS-CoV-2 infections with the delta variant than the omicron variant. Strict societal restrictions could control spread of the virus, but relief of the restrictions was associated with an increase in omicron infections. No significant difference in SARS-CoV-2 infections were found when comparing countries or territories which did or did not implement a COVID pass.https://www.mdpi.com/2076-393X/11/9/1407COVID passSARS-CoV-2 antigen testSARS-CoV-2 antibodiessocietal restrictions |
spellingShingle | Jasmijn Stroo Michaëla Lepolder Jean-Luc Murk Ger T. Rijkers The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World Vaccines COVID pass SARS-CoV-2 antigen test SARS-CoV-2 antibodies societal restrictions |
title | The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World |
title_full | The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World |
title_fullStr | The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World |
title_full_unstemmed | The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World |
title_short | The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World |
title_sort | impact of sars cov 2 immune status and societal restrictions in controlling covid 19 across the world |
topic | COVID pass SARS-CoV-2 antigen test SARS-CoV-2 antibodies societal restrictions |
url | https://www.mdpi.com/2076-393X/11/9/1407 |
work_keys_str_mv | AT jasmijnstroo theimpactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT michaelalepolder theimpactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT jeanlucmurk theimpactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT gertrijkers theimpactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT jasmijnstroo impactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT michaelalepolder impactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT jeanlucmurk impactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld AT gertrijkers impactofsarscov2immunestatusandsocietalrestrictionsincontrollingcovid19acrosstheworld |